Tag Archives: belimumab

IgAN Therapy – It’s Getting Crowded Out There

Posted on by — No Comments ↓

Earlier this year, the NEJM published interim data on atacicept and sibeprenlimab in IgAN, both well-designed Phase 3 pivotal registration trials of promising drugs [1],[2]. Sponsors were clearly anxious to show the world how well their drug is working, but why publish interim results?  After all, IA data are usually Continue reading IgAN Therapy – It’s Getting Crowded Out There→

TELITACICEPT IN SLE

Posted on by — No Comments ↓

In today’s blog we will share our thoughts about a recent NEJM article, entitled “A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus”.[1] Publications on SLE literally come with a book of abbreviations and definitions nowadays and are not an easy Sunday reads.  Of course, there is extensive literature Continue reading TELITACICEPT IN SLE→